Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis.
Paolo PreziosaLoredana StorelliNicolò TedoneMonica MargoniDamiano MistriMatteo AzzimontiMassimo FilippiMaria Assunta RoccaPublished in: Molecular psychiatry (2024)
In multiple sclerosis (MS), a non-random and clinically relevant pattern of gray matter (GM) volume loss has been described. Whether differences in regional gene expression might underlay distinctive pathological processes contributing to this regional variability has not been explored yet. Two hundred eighty-six MS patients and 172 healthy controls (HC) underwent a brain 3T MRI, a complete neurological evaluation and a neuropsychological assessment. Using Allen Human Brain Atlas, voxel-based morphometry and MENGA platform, we integrated brain transcriptome and neuroimaging data to explore the spatial cross-correlations between regional GM volume loss and expressions of 2710 genes involved in MS (p < 0.05, family-wise error-corrected). Enrichment analyses were performed to evaluate overrepresented molecular functions, biological processes and cellular components involving genes significantly associated with voxel-based morphometry-derived GM maps (p < 0.05, Bonferroni-corrected). A diffuse GM volume loss was found in MS patients compared to HC and it was spatially correlated with 74 genes involved in GABA neurotransmission and mitochondrial oxidoreductase activity mainly expressed in neurons and astrocytes. A more severe GM volume loss was spatially associated, in more disabled MS patients, with 44 genes involved in mitochondrial integrity of all resident cells of the central nervous system (CNS) and, in cognitively impaired MS patients, with 64 genes involved in mitochondrial protein heterodimerization and oxidoreductase activities expressed also in microglia and endothelial cells. Specific differences in the expressions of genes involved in synaptic GABA receptor activities and mitochondrial functions in resident CNS cells may influence regional susceptibility to MS-related excitatory/inhibitory imbalance and oxidative stress, and subsequently, to GM volume loss.
Keyphrases
- multiple sclerosis
- oxidative stress
- mass spectrometry
- ms ms
- white matter
- gene expression
- induced apoptosis
- end stage renal disease
- newly diagnosed
- endothelial cells
- chronic kidney disease
- ejection fraction
- genome wide
- prognostic factors
- dna damage
- patient safety
- resting state
- cell cycle arrest
- high throughput
- mild cognitive impairment
- inflammatory response
- functional connectivity
- computed tomography
- magnetic resonance imaging
- ischemia reperfusion injury
- signaling pathway
- rna seq
- brain injury
- neuropathic pain
- contrast enhanced
- machine learning
- artificial intelligence
- patient reported
- heat shock
- cognitive decline
- single molecule
- high grade
- subarachnoid hemorrhage
- cerebrospinal fluid